Loading...
XNYS
SOLV
Market cap14bUSD
Dec 05, Last price  
85.43USD
1D
0.20%
1Q
17.48%
IPO
23.63%
Name

Solventum Corp

Chart & Performance

D1W1MN
XNYS:SOLV chart
P/E
30.80
P/S
1.79
EPS
2.77
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
8.25b
+0.70%
7,281,000,0008,171,000,0008,130,000,0008,197,000,0008,254,000,000
Net income
479m
-64.41%
1,138,000,0001,460,000,0001,343,000,0001,346,000,000479,000,000
CFO
1.19b
-38.12%
2,026,000,0002,202,000,0001,679,000,0001,915,000,0001,185,000,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
IPO date
Mar 26, 2024
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT